SCHEMBL7874829

SCHEMBL7874829

CCOC(=O)NCCSC(C)(C)[C@H](N)C(=O)Nc1nccs1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
PKM P14618 4/20 0.47
MAPT P10636 2/20 0.43
HTT P42858 2/20 0.43
RAB9A P51151 2/20 0.43
MEN1 O00255 1/20 0.43
GAA P10253 1/20 0.43
KMT2A Q03164 1/20 0.43
LMNA P02545 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
HSPA5 P11021 3/20 0.40
HSPA2 P54652 1/20 0.40
FFAR2 O15552 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7876536 0.87 HDAC6 (0.51) PKMLMNAL3MBTL1SMN1; SMN2TSHR
SCHEMBL7879190 0.77 PKM (0.54) ALDH1A1PKMMAPTHTTRAB9A
SCHEMBL4119851 0.72 HSPA5 (0.57) MAPTMEN1KMT2ALMNATSHR
SCHEMBL6056907 0.72 HSPA5 (0.57) MAPTMEN1KMT2ALMNATSHR
SCHEMBL7421285 0.72 HDAC6 (0.47) PKMMAPTL3MBTL1SMN1; SMN2MAPK1
SCHEMBL8366793 0.72 PKM (0.74) ALDH1A1PKMMAPTHTTRAB9A
SCHEMBL7873389 0.71 HSPA5 (0.53) MAPTMEN1KMT2ALMNATSHR
Hydrochloric Acid SCHEMBL7422746 0.71 HSPA5 (0.56) MAPTMEN1KMT2ALMNATSHR
SCHEMBL11221591 0.66 PKM (1.00) ALDH1A1PKMMAPTHTTRAB9A
SCHEMBL5875678 0.66 CYP1A2 (0.62) ALDH1A1PKMLMNAL3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329400-B1 INHIBITION OR ANTAGONISM OF MATRIX METALLOPROTEASES, AND/OR TUMOR NECROSIS FACTOR-ALPHA; EXTRACELLULAR MATRIX DEGRADATION, INHIBITION OF SHEDDING OF CELL SURFACE PROTEIN ECTODOMAINS AND CD23 PROTEOLYSIS GLAXO WELLCOME INC. 2001-12-11 US disclosed